Extrahepatic autoimmune diseases in primary biliary cholangitis: Prevalence and significance for clinical presentation and disease outcomeCumali Efe, Staffan Wåhlin, Maneerat Chayanupatkul et al.|Journal of Gastroenterology and Hepatology|2020Cited by 68
Validation of Risk Scoring Systems in Ursodeoxycholic Acid–Treated Patients With Primary Biliary CholangitisCumali Efe, Staffan Wåhlin, Koray Taşçılar et al.|The American Journal of Gastroenterology|2019Cited by 48
Efficacy and safety of infliximab in patients with autoimmune hepatitisCumali Efe, Fatima Higuera‐de la Tijera, Ellina Lytvyak et al.|Hepatology|2024Cited by 25
Ursodeoksikolik asit ile tedavi edilen Primer biliyer kolanjitli hastalarda risk skorlama sistemlerinin yeterliliklerinin değerlendirilmesi. Uluslarasrası çok merkezli çalışma (SS-003)Murat Kıyıcı, Savas Cumali Efe, Fatih Eren et al.|Bursa Uludag University - AVESIS|2018Cited by 0